Increase In The Need For Accurate Disease Diagnosis Is Driving The Lipidomics Services Market.

According to Precision Business Insights (PBI) latest report, The Lipidomics Services Market is expected to be worth USD 55 million in 2022, growing at an 8% CAGR from 2022 to 2028. Global Lipidomics Services Market is segmented into the following types: By Service Type (Lipid Separation Services, Lipid Identification Services), By Sample Type (Blood Sample, Tissue Sample), By Sample Source (Animal, Human, Plant), By End User (Healthcare Industry, Food Processing Industry, Cosmetic Industry, Academic & Research Institutes), and Geography (North America, Europe, Asia Pacific, Latin America, and MEA) and Forecast to 2028. Key player's profiles in the Lipidomics Services market report are Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (the Netherlands, Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), and Axel Bio Corporation (U.S.). The development and launch of newer platforms in the adoption of advanced analytical instruments and software by the market players are anticipated to boost the lipidomics services market over the forecast period. Qualitative and quantitative analysis of multiple lipids in a single injection with a significantly less sample reduces the time and cost. For instance, In January 2018, Sciex Diagnostics launched the Citrine Triple Quad MS/MS and Citrine Qtrap MS/MS systems to measure trace levels of biomarkers and metabolites at sub-pg/mL concentrations.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/lipidomics-services-market/

Academic & Research Institutes End-User Segment Leading the Lipidomics Services Market
The academic & research institutes segment is expected to account for a larger revenue share in the global Lipidomics Services market, with a significant value share worldwide. It is projected to grow at an 8.6% CAGR between 2022 and 2028. Academic and research institutes are attributed to raising funds from public and private sectors for R & D activities and having low service costs compared with industries for lipid analysis. The growth of this segment is expected to be fuelled by factors such as technological advancements in analytical instruments in terms of miniaturization, automation, and computerization; an increase in the number of research-related activities worldwide in the fields of medicine, nutraceuticals, and metabolomics; and the strengthening of healthcare infrastructure in developing countries for efficient disease diagnosis and treatment.

Europe Lipidomics Services Market
Europe is expected to hold a significant market share in the global lipidomics services market over the forecast period. It is projected to grow at a CAGR of 8.5% in the coming years. A growing number of pharmaceutical, biotechnology, and food industries is expected to fuel the market over the forecast years. Technological advancements in instruments and software for lipidomics services and raising funds from government and private policies drive the market in the European region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.
Global Lipidomics Services market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In May 2017, Sanyal Biotechnology LLC and One Way Liver S.L. (OWL Metabolomics) expanded their existing strategic partnership to grow one another's businesses overseas.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=25054

Detailed Segmentation
Lipidomics Services Market is segmented based on service type, sample type, sample source, end-user, and geography.
Based on the service type, the market is segmented into the following:
• Lipid Separation Services
• Lipid Identification Services

Based on the sample type, the market is segmented into the following:
• Blood Sample
• Tissue Sample

Based on the sample source, the market is segmented into the following:
• Animal
• Human
• Plant

Based on the end-user, the market is segmented into the following:
• Healthcare Industry
• Food Processing Industry
• Cosmetic Industry
• Academic & Research Institutes

Based on the geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.